Aquatic_Training in Obese Women
- Disease/Condition
- Obesity
- Drug/Device/Intervention
- 10-week water-based aerobic training
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- University of Taipei
- Location
- Taipei, Taiwan
- Phase
- N/A
- Start date
- Jan 02, 2019
- End date
- Mar 30, 2019
- Enrollment
- 31 participants
fasting glycemia in millimoles per liter,total cholesterol in millimoles per liter,high-density lipoprotein cholesterol in millimoles per liter,low-density lipoprotein cholesterol in millimoles per liter,triglyceride concentrations in millimoles per liter,systolic blood pressure in millimeters of mercury,diastolic blood pressure in millimeters of mercury,heart rate in beat per minute,fasting glycemia in millimoles per liter,total cholesterol in millimoles per liter,high-density lipoprotein cholesterol in millimoles per liter,low-density lipoprotein cholesterol in millimoles per liter,triglyceride concentrations in millimoles per liter,systolic blood pressure in millimeters of mercury,diastolic blood pressure in millimeters of mercury,heart rate in beat per minute
This study aims to assess the effects of 10-week water-based aerobic training (thrice a week)
 on anthropometrics, biochemicals, cardiovascular parameters, and explosive strength in young
 overweight and obese women. The findings indicate that water-based aerobic training could be
 a useful program to enhance body composition, biochemical, cardiovascular, and explosive
 strength parameters in young overweight and obese women compared to inactive persons
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06371105
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06371105 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Taipei and is currently Completed. The study focuses on Obesity. Target enrollment is 31 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.